Karnauskas Favors Amgen Purchase of Onyx (Audio)

Robyn Karnauskas, a New York-based analyst at Deutsche Bank AG, says Amgen's purchase of Onyx Pharmaceuticals Inc. (ONXX) gives Amgen "top line growth" in the cancer-drug market. Karnauskas talks with Bloomberg's Tom Keene and Joe Brusuelas on Bloomberg Radio's "Bloomberg Surveillance."

(Source: Bloomberg)

Running time 05:38

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.